Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 143.15
+1.15 (0.81%)
Sep 9, 2025, 2:37 PM GMT+1
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 120.15 million as of September 9, 2025. Its market cap has increased by 7.39% in one year.
Market Cap
120.15M
Enterprise Value
108.46M
Revenue
32.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
143.15
Market Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 120.15M, an increase of 80.80%. That is a compound annual growth rate of 9.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 120.15M | 13.27% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | 112.23M | 58.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |